Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Changes In Equity

v3.20.4
Consolidated Statements Of Changes In Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Loss
Noncontrolling Interests in Subsidiaries
Total equity, beginning balance at Dec. 31, 2017 $ 753,361 $ 387 $ 1,573,013 $ 419,128 $ (1,368,300) $ (545) $ 129,678
Issuance of common stock:              
Employee Stock Purchase Plan 1,527       1,527    
Exercise of stock options 6,883 2 6,881        
Director stock awards 140   140        
Restricted stock 0 1 (1)        
Exercise of conversion option in convertible debt 12,735   12,735        
Purchase of conversion option in convertible debt, net of tax (33)   (33)        
Amortization of share awards 3,907   3,907        
Purchase of subsidiary shares from noncontrolling interests, net of tax (29)           (29)
Acquisition of a subsidiary with noncontrolling interests 96           96
Distributions to noncontrolling interests (5,111)           (5,111)
Net Income 83,202     58,148     25,054
Other comprehensive loss (369)         (369)  
Total equity, ending balance at Dec. 31, 2018 853,842 390 1,596,642 474,809 (1,366,773) (914) 149,688
Issuance of common stock:              
Employee Stock Purchase Plan 1,695       1,695    
Exercise of stock options 5,244 1 5,243        
Director stock awards 97   97        
Restricted stock 0 2 (2)        
Purchase of conversion option in convertible debt, net of tax (115)   (115)        
Purchase of treasury shares (525)       (525)    
Amortization of share awards 5,134   5,134        
Cancellation of restricted stock 0   189   (189)    
Purchase of subsidiary shares from noncontrolling interests, net of tax (106,989) 15 53,814       (160,818)
Distributions to noncontrolling interests (5,162)           (5,162)
Net Income 34,018     26,774     7,244
Other comprehensive loss (84)         (84)  
Total equity, ending balance at Dec. 31, 2019 812,514 408 1,661,002 517,106 (1,365,792) (998) 788
Issuance of common stock:              
Employee Stock Purchase Plan 1,815       1,815    
Exercise of stock options 4,432 1 4,431        
Director stock awards 72   72        
Restricted stock 0 2 (2)        
Purchase of treasury shares (1,961)       (1,961)    
Amortization of share awards 6,366   6,366        
Distributions to noncontrolling interests (2)           (2)
Net Income 23,331     23,311     20
Other comprehensive loss (1,150)         (1,150)  
Total equity, ending balance at Dec. 31, 2020 $ 845,417 $ 411 $ 1,671,869 $ 540,417 $ (1,365,938) $ (2,148) $ 806